A copy of the presentation materials can be accessed on the “ Publication ” section of the Company’s website at www.bioatla.com once the presentations have concluded.

BioAtla (BCAB) announced preclinical poster presentations at the upcoming 2025 American Association for Cancer Research to be held at the ...

Additionally, as previously announced, an oral presentation regarding Emi-Le will be given at the ESMO Breast Cancer 2025 Annual Congress in Munich, Germany on Thursday, May 15, 2025. This ...

2025 at 4:00 pm during Oral Poster Presentation: Research 3 at NKF SCM25, Dr. Wolfgang Winkelmayer will present a poster titled “Vadadustat for Treatment of Anemia in Older vs Younger Patients ...

Two posters will highlight new data from the company’s open-label ASCENT study of LIQ861 (YUTREPIA) in PH-ILD patients with a focus on safety, tolerability, exploratory changes in 6-minute walk ...

RaySearch Laboratories AB (publ) announces that Odense University Hospital (OUH), which is part of the South Denmark Region, has placed an order for RayStation®*. The radiotherapy center at OUH is ...

including during two oral presentations, and we look forward to sharing our clinical safety and PK/PD data with PLX-4545," said Jorge F. DiMartino, MD, PhD, Chief Medical Officer of Plexium.

PPBT), a clinical-stage company developing first-in-class therapies that seek to overcome tumor immune evasion and drug resistance, today announced upcoming poster presentations including one for CM24 ...

About GRI Bio, Inc. GRI Bio is a clinical-stage biopharmaceutical company focused on fundamentally changing the way inflammatory, fibrotic and autoimmune diseases are treated. GRI Bio’s therapies are ...

Three Gallaudet Biology students won honors and cash prizes in this year's NASA DC Space Grant Consortium’s student poster ...

He has served as Principal Investigator in over 90 clinical trials, authored more than 60 peer-reviewed publications and textbook chapters, and regularly presents at national and international ...